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involved in complex traits. A recent 
review article makes this point and 
goes on to show that, surprisingly, the 
rate of discovery of disease genes has 
actually decreased since the genome 
was completed, even though posi-
tional cloning and positional can-
didate genetics are easier than ever 
before (Antonarakis and Beckmann, 
2006). Part of the reason is that fund-
ing agencies and, presumably, a good 
number of peer reviewers regard rare 
mendelian traits as easy to solve and 
not worthy of funding. The fact of the 
matter is that most disease genes, 
including many involved in complex 
traits or cancer, have emerged from 
monogenic disorders. For example, 
the patched gene was identified by 
study of the very rare Gorlin syndrome 
but is a major player in basal-cell car-
cinoma, the most common human 
cancer. We accept that filaggrin is an 
unusual example of the genre, and 
we agree that a large-scale approach 
to complex traits is required, but we 
would suggest that a more balanced 
view be taken, as so much of what 
we know about basic genetic mecha-
nisms underlying both common and 
rare disorders continues to come from 
the mendelian camp.
Our work on filaggrin has firm-
ly established an important role of 
the keratinocyte and the epidermal 
barrier formation in atopic derma-
titis. As the epidermal differentia-
tion complex locus on 1q21 is also 
known to harbor a psoriasis suscep-
tibility gene (Bowcock and Cookson, 
2004), we posit that a barrier defect 
is also involved in this complex trait. 
Furthermore, an autosomal dominant 
form of the follicular occlusion dis-
order hidradenitis suppurativa was 
recently linked to a large interval con-
taining the epidermal differentiation 
complex (Gao et al., 2006). Thus, the 
importance of maintaining a sound 
barrier in the skin and its appendages 
may come to the fore in genoderma-
tology in the near future.
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Epidermal Differentiation Complex 
Yields a Secret: Mutations in the 
Cornification Protein Filaggrin 
Underlie Ichthyosis Vulgaris
Julia A. Segre1
Ichthyosis vulgaris (IV), characterized by mild scaling on limbs and lower 
abdomen, has an incidence of 1 in 250. Smith, McLean, and colleagues dem-
onstrate that common mutations in filaggrin underlie IV. Filaggrin aggregates 
keratin intermediate filaments and is cross-linked into the cornified envelope 
to form the epidermal barrier. These findings reinforce the importance of the 
epidermal barrier in pathogenesis of skin diseases.
Journal of Investigative Dermatology (2006) 126, 1202–1204. doi:10.1038/sj.jid.5700367
Ten years ago the phrase “epidermal 
differentiation complex” (EDC) was 
first coined in this journal to describe 
the 1.6-Mb locus on human chromo-
some 1q21 that contains more than 30 
genes encoding both epidermal corni-
fication and S100 proteins (Mischke 
et al., 1996). Now, finally, the EDC 
has revealed one of its most guarded 
secrets: Resident in this gene com-
plex is the cause of the very common 
skin disorder ichthyosis vulgaris (IV) 
(OMIM 146700). In a recent report in 
Nature Genetics, Smith, McLean, and 
colleagues have convincingly dem-
onstrated that mutations in the gene 
encoding filaggrin (FLG), the keratin 
filament-aggregating protein, under-
lie IV (Smith et al., 2006). Twenty 
years ago, a defect in the synthesis 
of FLG was observed in IV patients 
(Sybert et al., 1985). Four years ago, 
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genetic linkage between the EDC and 
a sub-phenotype of IV was confirmed 
(Compton et al., 2002). So why did it 
require a tour de force genetic study, 
harnessing all of the resources of the 
human genome project, to prove that 
mutations in FLG protein underlie IV? 
The answer to this question lies in the 
unique genetic and genomic structure 
of the EDC, which will also be dis-
cussed in this Commentary.
IV is characterized by fine white 
scale over the lower abdomen, arms, 
and legs. Palmar hyperlinearity and 
keratosis pilaris are also commonly 
associated with IV. Typically, patients 
have normal skin as infants, and the 
disease manifests within the first 
year. IV is often exacerbated by dry, 
cold climates and improved in warm, 
humid environments. A classic study 
in 1966 examined 6,051 healthy 
English schoolchildren and deter-
mined that one in 250 was affected 
with IV (Wells and Kerr, 1966). Initial 
genetic studies hinted that IV has a 
wide range of expressivity and incom-
plete penetrance; that is, obligate 
carriers with both an affected parent 
and child were themselves either very 
mildly or not at all affected with IV.
The histology of affected areas of 
IV shows mild hyperkeratosis with a 
diminished or absent granular layer. 
FLG is a major component of the 
keratohyalin granules and is absent 
or markedly reduced in the skin and 
keratinocytes derived from IV patients 
(Sybert et al., 1985). Keratins are bun-
dled into macrofibrils through their 
association with FLG while the corni-
fied envelope is being assembled and 
cross-linked by the transglutaminase 
enzyme to form the epidermal barrier. 
IV patients have been shown to have 
a mildly impaired epidermal perme-
ability barrier or barrier recovery. So, 
why not close the case and declare 
defects in FLG to be the cause of IV? 
First, the decreased level of FLG may 
have resulted from an altered cell 
fate of the epidermis. Basically, if IV 
patients have an attenuated granular 
layer and granular cells synthesize 
FLG, then of course IV patients will 
have decreased FLG protein. As for the 
genetic studies, linkage to the EDC on 
1q21 shows association with FLG and 
approximately 30 other genes that 
also play an important role in either 
forming or regulating the barrier. As 
well, one could imagine that the cause 
of IV was a mutation in a regulatory 
sequence that determined a stress 
response rather than a null or mis-
sense mutation in coding sequence.
The delay in finding the mutations 
in FLG that underlie IV is due to the 
unusual structure of the FLG gene. 
FLG is an enormously large tran-
script encoded by three exons. Exon 
1 (15 bp) encodes only untranslated 
sequence. Exon 2 (159 bp) contains 
the translation initiation codon. Exon 3 
is 12–14 kb, depending on the individ-
ual, and encodes the N-terminal por-
tion of the protein and repeated cop-
ies of an approximately 1-kb sequence 
that encode the proteolytically cleaved 
portions of FLG. A 12-kb exon would 
always be tricky to amplify, but the 
added difficulty is that this exon can-
not be amplified in sections, as it pri-
marily contains an identical sequence 
repeated 10–12 times. It seems that 
the few specific bases that were found 
in the FLG repeats, which might have 
been used to anchor primers, often 
turned out to be polymorphisms 
between individuals. Ultimately, 
Smith, McLean, and colleagues (Smith 
et al., 2006) relied on the experience 
they had gained 10 years earlier while 
sequencing the terminal exon of the 
plectin gene, which similarly con-
sists of approximately 1-kb repeats, to 
sequence FLG’s entire terminal exon. 
Retaining the register of the repeats 
and not merely resequencing the same 
repeat ten times was a challenge over-
come by long-range sequencing and 
multiple alignments.
To determine whether mutations 
in FLG underlie IV, Smith, McLean, 
and colleagues (Smith et al., 2006) 
sequenced the gene in a family with 
strong linkage to 1q21, seven unre-
lated IV families, and eight addition-
al sporadic cases. Ultimately, they 
found two mutations in the first repeat 
domain of FLG: R501X and 2282del4. 
Both of these mutations create stop 
codons in the first repeat, result-
ing in no proteolytically processed 
FLG. Remarkably, these mutations 
were found at a combined allele fre-
quency of approximately 4% among 
populations of European ancestry. This 
translates into one in 25 individuals 
being heterozygous and one in 2,500 
being homozygous for FLG mutations. 
Genetic analysis of the pedigrees 
supported a semidominant mode of 
inheritance, as all severely affected 
IV patients are homozygous for FLG 
mutations and all mildly affected IV 
patients are heterozygous for FLG 
mutations. Interestingly, two hetero-
zygous patients appear unaffected, 
reinforcing the original concept that 
IV has incomplete penetrance. Finally, 
immunohistochemical staining indi-
cated that the proteolytically pro-
cessed FLG repeats are absent from 
a severely affected IV patient, homo-
zygous for FLG mutations. However, 
the N-terminal portion of FLG is still 
expressed, albeit at a lower level with 
patchy staining.
One feature of genes in the EDC 
is that all or almost all of the coding 
sequence is contained in the termi-
nal exon. FLG is a founding member 
of the now expanded family of EDC 
genes that encode “fused” S100 pro-
teins (Huber et al., 2005). These pro-
teins contain calcium-binding hands 
of the S100 type and internal tandem 
repeats characteristic of cornified 
envelope precursor proteins. In addi-
tion to FLG, the fused proteins include 
filaggrin 2, trichohyalin, trichohyalin 
2, repetin, cornulin, and hornerin. 
These proteins are associated with 
the keratin intermediate filaments and 
partially cross-linked to the corni-
fied envelope. These fused S100 pro-
teins have two tiny exons and a large 
terminal coding exon. For other EDC 
genes, such as late cornified envelope 
and small proline-rich genes, loricrin, 
and involucrin, there is only a tiny first 
|
 All severely affected 
IV patients are 
homozygous for FLG 
mutations and all mildly 
affected IV patients are 
heterozygous for FLG 
mutations.
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non-coding exon and then a large 
coding second exon. One explanation 
for the large terminal exon is that the 
encoded repeats have been “recently” 
created by unequal crossing over or 
gene conversion, which constrains 
them to one exon. Alternatively, there 
may be an evolutionary advantage to 
maintaining the coding sequence of 
these proteins in the terminal exons. 
Splicing of an intron has been shown 
to increase mRNA stability, with the 
assumption that the cell uses this to 
distinguish a bona fide gene from a 
pseudogene. However, if a termination 
codon is detected while the mRNA is 
still being spliced (that is, in any exon 
more than 50 bp from the terminal 
exon), then the mRNA is subject to 
nonsense-mediated decay, presumably 
to protect against the creation of trun-
cated proteins with dominant-nega-
tive activity. Genes expressed from the 
EDC are unique in that the proteins 
they encode are typically expressed 
only as the cell is terminally differen-
tiating and becoming enucleated. EDC 
proteins are substrates for the transglu-
taminase enzyme, which cross-links 
the cornified envelope. A chimeric 
protein might still have some biologi-
cal function as a partial substrate for 
the transglutaminase enzyme.
The mutations identified in these 
IV patients are both in the first FLG 
repeat. It will be interesting to see 
whether additional mutations are 
identified in more terminal repeats 
that would still result in the expression 
of some FLG fragments. Obviously, 
being homozygous for the mutation 
is more deleterious than being hetero-
zygous, so there is some advantage to 
attaining expression of FLG fragments. 
Conversely, both of these mutations 
occur after the sequences that encode 
the N-terminal fragment of FLG. The 
immunohistochemical data suggest 
that processing of FLG may still occur 
to produce this N-terminal fragment. 
Previous reports have shown that the 
N-terminal S100-like calcium-bind-
ing domain of FLG enters the nucleus, 
where it may have a role in regulat-
ing terminal differentiation (Pearton 
et al., 2002). So, would a null allele 
of FLG that did not express the N-
terminal domain have an even more 
severe phenotype?
Why do the R501X and 2282del4 
mutations in FLG not result in a 
more severe phenotype? Although 
the other fused S100 proteins 
have unique expression patterns 
under homeostatic conditions, 
are they upregulated to compen-
sate for the loss of proteolytically 
processed FLG repeats? Does the level 
of the other fused S100 proteins cor-
relate with the phenotypic severity to 
explain the range of penetrance and 
expressivity observed with IV? One 
example of this is the barrier acqui-
sition defect in utero of loricrin-defi-
cient mice, which is rescued by com-
pensatory upregulation of other EDC 
proteins (Koch et al., 2000). Will all 
patients with IV turn out to have muta-
tions in FLG? Or will there be under-
lying genetic diversity in the spectrum 
of proteins that can result in IV when 
mutated? Does the spontaneously 
occurring mouse mutant flaky tail, 
which has strong genetic linkage to 
the EDC and shows histologic features 
of IV, have a mutation in the Flg gene 
(Presland et al., 2000)? Will haired 
mice be suitable animal models for 
adult human skin disorders, such as 
IV? And finally: With a carrier fre-
quency of 4%, this is one of the most 
common genetic disorders. Why has a 
mutation that results in impaired bar-
rier or barrier recovery become fixed 
in the European population? Could 
there be some evolutionary advantage 
to having a mildly impaired barrier?
In conclusion, the discovery that 
common mutations in FLG underlie 
the common skin disorder ichthyosis 
vulgaris answers many questions and 
raises as many more. Are there more 
secrets locked inside the EDC? Will 
we discover mechanisms that coordi-
nate gene regulation in the EDC under 
homeostatic or stressed conditions? 
One more secret has been yielded. 
Psoriasis and atopic dermatitis both 
show genetic linkage to the EDC. In 
a commentary accompanying this 
one, Irvine and Irwin McLean (2006) 
explain that these same common 
mutations in FLG are a major predis-
posing factor for atopic dermatitis 
(Palmer et al., 2006).
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